Abstracts tagged "Quality Indicators and rheumatoid arthritis (RA)"

Abstract Number: 3137 • 2016 ACR/ARHP Annual Meeting
Assessing System-Level Performance Measures for Early Rheumatoid Arthritis in a Large Multicenter Cross-Country Prospective 8-Year Observational Cohort Study
Claire E H Barber¹, Cheryl Barnabe², Glen Hazlewood², Orit Schieir³, Lyne Nadeau⁴, J Carter Thorne⁵, Vandana Ahluwalia⁶, Susan J. Bartlett⁷, Gilles Boire⁸, Boulos Haraoui⁹, Carol Hitchon¹⁰, Edward Keystone¹¹, Diane Tin¹², Janet E. Pope¹³, Lisa Denning¹⁴, Vivian P. Bykerk¹⁵ and Canadian early Arthritis Cohort (CATCH) Investigators, ¹University of Calgary, Calgary, AB, Canada, ²Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ³Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, ⁴McGill University, Qubec, QC, Canada, ⁵Southlake Regional Health Centre, Newmarket, ON, Canada, ⁶Ontario Rheumatology Association, Brampton, ON, Canada, ⁷Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁸Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, ⁹Institute de Rheumatologie, Montreal, QC, Canada, ¹⁰University of Manitoba, Winnipeg, MB, Canada, ¹¹Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada, ¹²The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹³University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ¹⁴William Osler Health System, Brampton, ON, Canada, ¹⁵Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: The Arthritis Alliance developed a set of 6 performance measures to evaluate timely access to care and treatment for inflammatory arthritis. A national study…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].